Fig. 1From: Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trialTreatment schedule of concurrent chemoradiotherapy in the DP groupCDDP: cisplatin; DOC: docetaxel; DP: docetaxel plus cisplatin; fr: fraction; PF: cisplatin plus 5-FUBack to article page